Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Buffers and Standards
  4. Chromatography Standards
  5. Drug Standards
  6. 01001928

CERILLIANT™ Remifentanil Hydrochloride Solution, 100 μg/mL in Methanol (as free base), Sold by MilliporeSigma™ Supelco™

Catalog No. 01001928 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
01-001-928 1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 01-001-928 Supplier MilliporeSigma Supelco Supplier No. R0241ML
Only null left
Add to Cart
Add to Cart

Description

Certified reference material

Remifentanil is a potent, short-acting, synthetic opioid analgesic drug. It is used in combination with other opioids and analgesics to induce or supplement general anaesthesia. This new certified reference solution is suitable for a variety of mass spectrometry-based testing applications including clinical toxicology, forensic analysis, workplace drug testing and pharmaceutical research.
TRUSTED_SUSTAINABILITY

Specifications

Packaging Ampule
CAS 67-56-1
Flash Point 9.7°C (49.5°F) - closed cup
Concentration 100 μg/mL in methanol (as free base)
Linear Formula C20H28N2O5 · HCl
MDL Number MFCD00910882
UN Number UN 1230 - class 3 - PG 2 - Methanol, solution
Quantity 1 mL
Formula Weight 412.91

CERILLIANT is a registered trademark of Cerilliant Corporation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.